ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 160 filers reported holding ITEOS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 6.56 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $856,761 | -20.3% | 78,243 | -3.7% | 0.00% | – |
| Q2 2023 | $1,075,631 | -5.0% | 81,241 | -2.3% | 0.00% | – |
| Q1 2023 | $1,131,726 | -53.2% | 83,154 | -32.9% | 0.00% | -100.0% |
| Q4 2022 | $2,419,025 | +4.7% | 123,862 | +2.2% | 0.00% | 0.0% |
| Q3 2022 | $2,310,000 | -8.3% | 121,240 | -0.9% | 0.00% | 0.0% |
| Q2 2022 | $2,520,000 | +52.4% | 122,346 | +138.1% | 0.00% | – |
| Q1 2022 | $1,654,000 | +43.1% | 51,387 | +107.0% | 0.00% | – |
| Q4 2021 | $1,156,000 | – | 24,829 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,738,785 | $52,174,000 | 19.87% |
| MPM BioImpact LLC | 1,745,943 | $33,260,000 | 7.88% |
| Boxer Capital, LLC | 2,154,058 | $41,035,000 | 2.31% |
| TANG CAPITAL MANAGEMENT LLC | 937,500 | $17,859,000 | 2.19% |
| RA Capital Management | 4,417,259 | $84,149,000 | 1.80% |
| BVF INC/IL | 1,810,835 | $34,496,000 | 1.42% |
| Zebra Capital Management LLC | 12,271 | $234,000 | 0.89% |
| Integral Health Asset Management, LLC | 195,000 | $3,715,000 | 0.72% |
| Prairiewood Capital, LLC | 32,269 | $615,000 | 0.51% |
| DAFNA Capital Management LLC | 97,560 | $1,859,000 | 0.50% |